Patents Assigned to Smart Targeting Limited
  • Neutralizing monoclonal antibody against human DLL4
    Patent number: 8404233
    Abstract: The present invention provides a binding protein capable of binding to delta-like ligand 4 (DLL4) as well as methods and uses thereof in therapy, diagnosis or imaging. Also provided are fusion proteins and protein conjugates, nucleic acid molecules encoding the binding proteins and methods of preparing binding proteins capable of binding to DLL4.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: March 26, 2013
    Assignee: Smart Targeting Limited
    Inventors: Makoto Sunamura, Hideo Yagita
  • NEUTRALIZING MONOCLONAL ANTIBODY AGAINST HUMAN DLL4
    Publication number: 20100303812
    Abstract: The present invention provides a binding protein capable of binding to DLL4 as well as methods and uses thereof in therapy, diagnosis or imaging. Also provided are fusion proteins and protein conjugates, nucleic acid molecules encoding the binding proteins and methods of preparing binding proteins capable of binding to DLL4.
    Type: Application
    Filed: May 15, 2008
    Publication date: December 2, 2010
    Applicant: Smart Targeting Limited
    Inventors: Makoto Sunamura, Hideo Yagita